Publications dans lesquelles il/elle collabore avec MARIA ANGELES MARTINEZ CUESTA (33)

2023

  1. Abacavir causes leukocyte/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin-like oxidized low-density lipoprotein receptor-1

    British Journal of Pharmacology, Vol. 180, Núm. 11, pp. 1516-1532

2021

  1. Abacavir Increases Purinergic P2X7 Receptor Activation by ATP: Does a Pro-inflammatory Synergism Underlie Its Cardiovascular Toxicity?

    Frontiers in Pharmacology, Vol. 12

2018

  1. Abacavir induces arterial thrombosis in a murine model

    Journal of Infectious Diseases

2017

  1. Abacavir induces platelet-endothelium interactions by interfering with purinergic signalling: A step from inflammation to thrombosis

    Antiviral Research, Vol. 141, pp. 179-185

2015

  1. Differential effects of anti-TNF-α and anti-IL-12/23 agents on human leukocyte-endothelial cell interactions

    European Journal of Pharmacology, Vol. 765, pp. 355-365

2014

  1. Efavirenz induces interactions between leucocytes and endothelium through the activation of Mac-1 and gp150,95

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 4, pp. 995-1004

2003

  1. Influence of cholecystitis state on pharmacological response to cholecystokinin of isolated human gallbladder with gallstones

    Digestive Diseases and Sciences, Vol. 48, Núm. 5, pp. 898-905

2001

  1. Comparative effects of the novel vasotocin analogue F-180 vs. vasopressin and terlipressin on systemic and splanchnic isolated vessels from portal hypertensive rats

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 364, Núm. 3, pp. 199-204

1998

  1. Mecanismos defensivos de la mucosa gastroduodenal

    Enfermedades digestivas (Grupo Aula Médica S.L.), pp. 549-555

1997

  1. Mecanismos defensivos de la mucosa gastrica: Bases funcionales y actuacion farmacologica

    Gastroenterologia y Hepatologia, Vol. 20, Núm. 4, pp. 196-208

  2. Nitric oxide modulates the acute increase of gastrointestinal transit induced by endotoxin in rats: A possible role for tachykinins

    Journal of Pharmacy and Pharmacology, Vol. 49, Núm. 10, pp. 988-990

  3. Pharmacological bases of therapy with 5-ASA

    Gastroenterología y hepatología, Vol. 20, Núm. 6, pp. 322-334

  4. Role of nitric oxide in gastric functions

    Methods and Findings in Experimental and Clinical Pharmacology

  5. Role of the endothelium in the relaxation induced by propofol and thiopental in isolated arteries from man

    Journal of Pharmacy and Pharmacology, Vol. 49, Núm. 4, pp. 430-432

  6. The effect of nitric oxide on the regulation of gastric blood flow

    Gastroenterología y hepatología, Vol. 20 Suppl 2, pp. 33-36

1996

  1. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 354, Núm. 4, pp. 474-480

  2. Involvement of prostaglandins and 5-hydroxytryptamine in the contractile effect of platelet-activating factor in rat isolated gastric corpus

    Journal of Pharmacy and Pharmacology, Vol. 48, Núm. 9, pp. 955-958

  3. Modulation by nitric oxide of spontaneous motility of the rat isolated duodenum: Role of tachykinins

    British Journal of Pharmacology, Vol. 118, Núm. 6, pp. 1335-1340

  4. Nitric oxide-mediated β2-adrenoceptor relaxation is impaired in mesenteric veins from portal-hypertensive rats

    Gastroenterology, Vol. 111, Núm. 3, pp. 727-735

1995

  1. Antiinflammatory activity and effects on isolated smooth muscle of extracts from different Teucrium species

    Phytotherapy Research, Vol. 9, Núm. 5, pp. 368-371